Invokana Lawsuit for Type 2 Diabetes Patients - Claim Info

Invokana Lawsuit for Type 2 Diabetes Patients

Start Claim Now

Type 2 diabetes patients who take the SGLT2 inhibitor Invokana may have an increased risk of suffering side effects like diabetic ketoacidosis, possibly leading to coma and death.

Type 2 diabetes accounts for more than 90% of diabetes cases diagnosed in the United States, and many patients suffering from Type 2 diabetes take a new generation of prescription medications called SGLT2 inhibitors. However, mounting evidence has indicated that Type 2 diabetes patients who take SGLT2 drugs like Invokana may have an increased risk of experiencing severe side effects like diabetic ketoacidosis, heart attack and kidney failure. If you believe you have been adversely affected by side effects of Invokana or another Type 2 diabetes medication, consult an experienced Invokana attorney to discuss your legal options. With a qualified drug injury lawyer on your side, you can ensure that your legal rights are protected and pursue the financial compensation you deserve for your injuries and medical expenses.
labtech-arrow-700

Invokana Alternatives for Type 2 Diabetes

There are a number of possible treatments for Type 2 diabetes, including prescription medications like Invokana and other SGLT2 inhibitors, alternative medicines and natural remedies. As concerns continue to mount regarding the potential side effects of Invokana and other prescription diabetes drugs, patients diagnosed with Type 2 diabetes may consider asking their doctor about other possible treatment options. In addition to making lifestyle changes related to diet and exercise, patients may try alternative diabetes treatments like:

  • Acupuncture
  • Chiropractic treatments
  • Guided imagery
  • Yoga
  • Hypnosis
  • Massage
  • Herbal remedies
  • Aromatherapy
  • Relaxation therapy

What is Invokana?

Prescription drug prescribed to help with glycemic control in adults with Type 2 diabetes.

Invokana LawsuitsInvokana (canagliflozin) belongs to a class of Type 2 diabetes medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors, which are designed to be used in combination with diet and exercise to lower blood glucose levels in adults with Type 2 diabetes. The prescription medication, approved by the U.S. Food and Drug Administration (FDA) in March 2013, functions by working with the kidneys to help excrete glucose through the process of urination, and is currently manufactured by Johnson & Johnson’s Janssen Pharmaceuticals unit. Although Invokana has only been on the market in the United States for a short time, the diabetes drug has already been linked to a potential risk of devastating side effects, including diabetic ketoacidosis (DKA).

Alleged Side Effects Leading to an Invokana Lawsuit

Since it first entered the market, Invokana has been aggressively marketed by Johnson & Johnson and Janssen Pharmceuticals as a safe and effective treatment for Type 2 diabetes. However, recent reports have suggested that diabetes patients taking SGLT2 inhibitors like Invokana may face an increased risk of serious medical complications that could potentially lead to death. Among the side effects allegedly linked to Invokana and other SGLT2 medications, like Invokamet (canagliflozin/metformin), Farxiga (dapagliflozin), Xigduo XR (dapagliflozin/metformin), Glyxambi (empagliflozin/linagliptin) and Jardiance (empagliflozin), are:

  • Kidney failure
  • Heart attack
  • Diabetic coma
  • Stroke
  • Diabetic ketoacidosis
  • Wrongful death
  • Breathing difficulty
  • Vomiting
  • Abdominal pain
  • Confusion
  • Frequent urination
  • Elevated levels ketones in urine
  • Excessive thirst
  • Unusual fatigue or sleepiness

Diabetic ketoacidosis, a subset of ketoacidosis or ketosis in diabetes patients, is a serious medical condition that occurs when the body produces high levels of ketones, or toxic acids in the bloodstream, which can lead to diabetic coma and death. According to reports, DKA typically develops in patients with Type 1 diabetes who also have high blood sugar levels. However, instances of diabetic ketoacidosis have been reported in patients with Type 2 diabetes who have only slightly increased blood sugar levels, when compared to typical cases of DKA, and this phenomenon is believed to be linked to the use of SGLT2 inhibitors like Invokana.

Link Between Invokana and Ketoacidosis

The first indication that Invokana treatment could put users at risk for serious side effects came in May 2015, following a search of the FDA’s Adverse Event Reporting System, which identified 20 instances of acidosis reported as diabetic ketoacidosis, ketoacidosis or ketosis in diabetes patients taking SGLT2 inhibitors like Invokana between March 2013 and June 6, 2014. According to the adverse event reports, all 20 cases included an emergency room visit or hospitalization in order for the patient to receive treatment for the ketoacidosis, and the FDA has indicated that the agency continues to receive reports of DKA side effects in Invokana patients.

The same month that the FDA issued its Invokana warning, the Institute for Safe Medication Practices (ISMP) released its own independent report based on adverse events submitted to the FDA, in which it highlighted the risk of kidney toxicity from the SGLT2 inhibitor. During the first year Invokana was on the market, the ISMP identified 457 serious adverse events reported to the FDA involving side effects of Invokana, and since these reports typically only account for a small percentage of the problem as a whole, it is likely that the risk of diabetic ketoacidosis, kidney failure and heart attack associated with Invokana treatment is significantly higher than originally believed.

Lawsuits Against Invokana for Diabetic Ketoacidosis

As more information comes to light about the alleged risk of diabetic ketoacidosis and other devastating side effects from Invokana, product liability lawsuits are expected to be brought against Johnson & Johnson and Janssen Pharmaceuticals, on behalf of consumers who believe they have been harmed by the Type 2 diabetes drug.

Why We Think Janssen Should Be Held Liable for Invokana Side Effects

Janssen_JJ_Image

Concerns continue to mount over the alleged side effects of Invokana, and critics have indicated that red flags were raised about the potential risks of the Type 2 diabetes medication before it was even approved by the FDA. According to a review of information taken into consideration by the FDA’s Endocrinologic and Metabolic Drug Advisory Committee prior to Invokana’s approval in 2013, the potential risk of heart problems and strokes from Invokana was brought to light before the SGLT2 inhibitor entered the market. Based on these findings, serious doubts have been raised about whether the minimal benefits offered by Invokana treatment justify the potential risks, and any Invokana lawsuits filed in the future over side effects like diabetic ketoacidosis and heart problems may allege the following:

  • Janssen Pharmaceuticals manufactured a defective medication
  • Janssen had a duty to ensure that Invokana was safe for consumer use before making it available to the public
  • Janssen failed to provide adequate warnings about the potential risk of diabetic ketoacidosis from Invokana treatment
  • Janssen failed to evaluate all data and safety information regarding the use of Invokana among Type 2 diabetes patients

What should you do? If you have experienced diabetic ketoacidosis or another serious side effect, you should contact a lawyer as soon as possible to discuss filing an Invokana drug injury lawsuit.

In light of the potential for Invokana and other SGLT2 inhibitors to cause diabetic ketoacidosis and other severe side effects in users, the FDA has advised healthcare professionals to be aware of the symptoms of DKA, evaluate for the presence of acidosis in patients with Type 2 diabetes, discontinue use of SGLT2 inhibitors like Invokana if acidosis is confirmed, and take appropriate measures to monitor glucose levels and correct the acidosis conmplications. If you took Invokana or another SGLT2 inhibitor in the past, and you have since suffered a potentially life-threatening side effect like diabetic ketoacidosis, contact a knowledgeable Invokana lawyer today for legal help. You may be entitled to financial compensation for your injuries, which you can pursue by filing an Invokana claim against Janssen Pharmaceuticals.

Start Claim Now
Do you deserve compensation?

An attorney will review your situation for FREE and help you found out what really went wrong.

How Can We Reach You?

Please Explain Your Situation

By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.
×